A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

Clinical trial NCT04511013 · RECRUITING

Trial details

NCT number: NCT04511013
Sponsor: SWOG Cancer Research Network
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acral Lentiginous Melanoma Clinical Stage IV Cutaneous Melanoma AJCC v8 Metastatic Cutaneous Melanoma Metastatic Malignant Neoplasm in the Brain Metastatic Melanoma Metastatic Mucosal Melanoma Pathologic Stage IV Cutaneous Melanoma AJCC v8

Start date: 2021-01-06
Primary completion: 2027-06-30
Enrollment: 112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.